Burden of Psychiatric Disorders among Pediatric and Young Adults with Inflammatory Bowel Disease: A Population-Based

Aravind Thavamani1, Krishna Kishore Umapathi1, Jasmine Khatana1

  • 1Department of Pediatrics, Case Western Reserve University (Metro Health) Program, Cleveland, OH, USA.

Insights

Psychiatric disorders are 5 times more likely in pediatric and young adult patients with inflammatory bowel disease (IBD). This study highlights the need for integrated mental health services for IBD care.

Area of Science:

  • Gastroenterology
  • Psychiatry
  • Public Health

Background:

  • Inflammatory bowel disease (IBD) affects a significant population, with growing recognition of associated psychiatric comorbidities.
  • Psychiatric disorders independently impact the quality of life for individuals with IBD.

Purpose of the Study:

  • To determine the prevalence of psychiatric disorders in pediatric and young adult patients diagnosed with IBD.
  • To analyze population-based data on the association between IBD and psychiatric conditions.

Main Methods:

  • Retrospective analysis of deidentified healthcare data from over 360 US hospitals.
  • Inclusion of patients aged 5-24 years with IBD (Crohn's disease or ulcerative colitis) and comparison with controls.
  • Predefined identification of 10 psychiatric disorders using Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT).

Main Results:

  • The study analyzed over 11.3 million patients, identifying 58,020 with IBD.
  • A prevalence of 21.6% for psychiatric disorders, primarily depression and anxiety, was observed in the IBD cohort.
  • IBD patients were 5 times more likely to have psychiatric disorders than controls (p<0.001), with a rising incidence trend from 2% in 2006 to 15% in 2017.

Conclusions:

  • This large population-based study confirms a significantly increased prevalence of psychiatric disorders among IBD patients.
  • Findings underscore the critical need to integrate psychological and mental health support into routine IBD clinical care.
  • Early identification and management of mental health conditions are crucial for improving outcomes in young IBD patients.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
705
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
878
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
811
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
581
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
413
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
683